| 1 | 1 | | 1 of 1 |
|---|
| 2 | 2 | | HOUSE DOCKET, NO. 3978 FILED ON: 1/20/2023 |
|---|
| 3 | 3 | | HOUSE . . . . . . . . . . . . . . . No. 1962 |
|---|
| 4 | 4 | | The Commonwealth of Massachusetts |
|---|
| 5 | 5 | | _________________ |
|---|
| 6 | 6 | | PRESENTED BY: |
|---|
| 7 | 7 | | James Arciero and Walter F. Timilty |
|---|
| 8 | 8 | | _________________ |
|---|
| 9 | 9 | | To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General |
|---|
| 10 | 10 | | Court assembled: |
|---|
| 11 | 11 | | The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill: |
|---|
| 12 | 12 | | An Act relative to non-opioid alternatives in pain treatment. |
|---|
| 13 | 13 | | _______________ |
|---|
| 14 | 14 | | PETITION OF: |
|---|
| 15 | 15 | | NAME:DISTRICT/ADDRESS :DATE ADDED:James Arciero2nd Middlesex1/20/2023Rodney M. Elliott16th Middlesex1/20/2023Michelle M. DuBois10th Plymouth2/7/2023Patrick Joseph Kearney4th Plymouth2/16/2023 1 of 2 |
|---|
| 16 | 16 | | HOUSE DOCKET, NO. 3978 FILED ON: 1/20/2023 |
|---|
| 17 | 17 | | HOUSE . . . . . . . . . . . . . . . No. 1962 |
|---|
| 18 | 18 | | By Representative Arciero of Westford and Senator Timilty, a joint petition (accompanied by |
|---|
| 19 | 19 | | bill, House, No. 1962) of James Arciero, Rodney M. Elliott and others relative to non-opioid |
|---|
| 20 | 20 | | alternatives in pain treatment. Mental Health, Substance Use and Recovery. |
|---|
| 21 | 21 | | The Commonwealth of Massachusetts |
|---|
| 22 | 22 | | _______________ |
|---|
| 23 | 23 | | In the One Hundred and Ninety-Third General Court |
|---|
| 24 | 24 | | (2023-2024) |
|---|
| 25 | 25 | | _______________ |
|---|
| 26 | 26 | | An Act relative to non-opioid alternatives in pain treatment. |
|---|
| 27 | 27 | | Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority |
|---|
| 28 | 28 | | of the same, as follows: |
|---|
| 29 | 29 | | 1 Section 1. Notwithstanding any general or special law to the contrary, The Massachusetts |
|---|
| 30 | 30 | | 2Department of Public Health shall develop and publish on its website an educational pamphlet |
|---|
| 31 | 31 | | 3regarding the use of non-opioid alternatives for the treatment of pain. The pamphlet shall |
|---|
| 32 | 32 | | 4include, but not be limited to, (i) information on available nonopioid alternatives for the |
|---|
| 33 | 33 | | 5treatment of pain, including non-opioid medicinal drugs or drug products and non- |
|---|
| 34 | 34 | | 6pharmacological therapies, (ii) the advantages and disadvantages of the use of non-opioid |
|---|
| 35 | 35 | | 7alternatives. |
|---|
| 36 | 36 | | 8 Section 2. Except when a patient is receiving care in a hospital critical care unit or |
|---|
| 37 | 37 | | 9emergency department or a patient is receiving hospice services under Part I, Title XVI, Chapter |
|---|
| 38 | 38 | | 10111, Section 227 of Massachusetts General Law, before providing care requiring the |
|---|
| 39 | 39 | | 11administration of anesthesia involving the use of an opioid drug listed as a Schedule II controlled |
|---|
| 40 | 40 | | 12substance in s. 893.03 or 21 U.S.C. s. 812, or prescribing or ordering an opioid drug listed as a 2 of 2 |
|---|
| 41 | 41 | | 13Schedule II controlled substance in s. 893.03 or 21 U.S.C. s. 812 for the treatment of pain, a |
|---|
| 42 | 42 | | 14health care practitioner who prescribes or orders an opioid drug shall (i) inform the patient or the |
|---|
| 43 | 43 | | 15patient’s representative of available nonopioid alternatives for the treatment of pain, which may |
|---|
| 44 | 44 | | 16include non-opioid medicinal drugs or drug products, interventional procedures or treatments, |
|---|
| 45 | 45 | | 17acupuncture, chiropractic treatments, massage therapy, physical therapy, occupational therapy, or |
|---|
| 46 | 46 | | 18any other appropriate therapy as determined by the health care practitioner, (ii) discuss with the |
|---|
| 47 | 47 | | 19patient or the patient’s representative the advantages and disadvantages of the use of non-opioid |
|---|
| 48 | 48 | | 20alternatives, including whether the patient is at a high risk of, or has a history of, controlled |
|---|
| 49 | 49 | | 21substance abuse or misuse and the patient’s personal preferences, (iii) provide the patient or the |
|---|
| 50 | 50 | | 22patient’s representative with a printed copy of the educational pamphlet described in section 1, |
|---|
| 51 | 51 | | 23(iv) document the non-opioid alternatives considered in the patient’s record. |
|---|